'For
the quarter ending Dec 2023, standalone Net sales (including other operating income) of Abbott India has increased 8.69% to Rs 1,437.14 crore compared to quarter ended Dec 2022. Operating profit margin has jumped from 23.61% to 26.98%, leading to 24.18% rise in operating profit to Rs 387.69 crore. Raw material cost as a % of total sales (net of stock adjustments) decreased from 11.43% to 8.07%. Purchase of finished goods cost rose from 39.41% to 46.24%. Employee cost decreased from 11.52% to 9.63%. Other expenses fell from 11.06% to 9.23%. Other income up 25.73% to Rs 55.61 crore. PBIDT rose 24.37% to Rs 443.3 crore. Provision for interest fell 16.36% to Rs 3.17 crore.
PBDT rose 24.81% to Rs 440.13 crore. Provision for depreciation rose 0.90% to Rs 17.97 crore.
Profit before tax grew 26.08% to Rs 422.16 crore. Provisio...
Pleaselogin & subscribe to view the full report.
More Reports
-
Sales up 10.26%, while PAT decreased by 2.44%.
-
-
OP up 46.05% and NP up 74.12%
-
(08-Nov-2024)
Sanofi India
|
|